Philip Scheltens < Philip Seeman < Philip Smith

Facettes :

List of bibliographic references indexed by Philip Seeman

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]

Ident.	Authors (with country if any)	Title
000429 (2016)	Serdar Durdagi [Turquie] ; Ramin Ekhteiari Salmas [Turquie] ; Matthias Stein [Allemagne] ; Mine Yurtsever [Turquie] ; Philip Seeman	Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques.
000601 (2015)	Philip Seeman [Canada]	Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
000981 (2014)	Craig J. Hudson [Canada] ; Philip Seeman [Canada] ; Mary V. Seeman [Canada]	Parkinson's Disease: Low-Dose Haloperidol Increases Dopamine Receptor Sensitivity and Clinical Response
000B24 (2014)	Philip Seeman [Canada]	Clozapine, a fast-off-D2 antipsychotic.
000C50 (2013)	James B. Koprich [Canada] ; Philippe Huot ; Susan H. Fox ; Keith Jarvie ; Anthony E. Lang ; Philip Seeman ; Jonathan M. Brotchie	The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques.
001038 (2013)	James B. Koprich [Canada] ; Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Keith Jarvie [Canada] ; Anthony E. Lang [Canada] ; Philip Seeman [Canada] ; Jonathan M. Brotchie [Canada]	The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques
001062 (2013)	Philip Seeman [Canada] ; Michele Tinazzi [Italie]	Loss of dopamine neuron terminals in antipsychotic-treated schizophrenia; relation to tardive dyskinesia
001459 (2012)	Terence K. Y. Lai [Canada] ; Philip Seeman [Canada] ; Fang Liu [Canada]	Cell membrane lytic action of metoclopramide and its relation to tardive dyskinesia
001889 (2011)	Sheng Chen [Canada] ; Philip Seeman [Canada] ; Fang Liu [Canada]	Antipsychotic drug binding in the substantia nigra: An examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia
002002 (2009)	Philip Seeman [Canada] ; Hong-Chang Guan [Canada]	Glutamate agonists for treating schizophrenia have affinity for dopamine D2High and D3 receptors
002003 (2009)	Philip Seeman [Canada] ; Hong-Chang Guan [Canada]	Glutamate agonist LY404,039 for treating schizophrenia has affinity for the dopamine D2High receptor
002019 (2009)	Philip Seeman [Canada]	Dopamine D2High receptors measured ex vivo are elevated in amphetamine‐sensitized animals
002305 (2008)	Philip Seeman [Canada] ; Carla Caruso [Argentine] ; Mercedes Lasaga [Argentine]	Memantine agonist action at dopamine D2High receptors
002333 (2008)	Philip Seeman [Canada]	Dopamine D2High receptors moderately elevated by bifeprunox and aripiprazole
002576 (2007)	Philip Seeman [Canada] ; Patrick N. Mccormick [Canada] ; Shitij Kapur [Canada]	Increased dopamine D2High receptors in amphetamine‐sensitized rats, measured by the agonist [3H](+)PHNO
002612 (2007)	Philip Seeman [Canada]	Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2High receptors
002804 (2006)	Philip Seeman [Canada] ; Johannes Schwarz [Allemagne] ; Jiang-Fan Chen [États-Unis] ; Henry Szechtman [Canada] ; Melissa Perreault [Canada] ; G. Stanley Mcknight [États-Unis] ; John C. Roder [Canada] ; Rémi Quirion [Canada] ; Patricia Boksa [Canada] ; Lalit K. Srivastava [Canada] ; Kazuhiko Yanai [Japon] ; David Weinshenker [États-Unis] ; Tomiki Sumiyoshi [Japon]	Psychosis pathways converge via D2High dopamine receptors
002999 (2005)	Philip Seeman [Canada] ; Françoise Ko ; Matth Us Willeit ; Patrick Mccormick ; Nathalie Ginovart	Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
002F82 (2002)	Philip Seeman [Canada]	Atypical antipsychotics: mechanism of action.
003071 (2002)	Philip Seeman [Canada] ; Bertha Madras [États-Unis]	Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis
003C09 (1997)	Philip Seeman [Canada] ; D. Roy Corbett [États-Unis] ; Hubert H. M. Van Tol [Canada]	Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Philip Seeman" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Philip Seeman" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Philip Seeman
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022